Global Alzheimer’s Platform Foundation
473290570
2015
Washington, DC 20005 United States
globalalzplatform.org
GAP_Foundation
GlobalALZPlatform
Podobné organizace
Podobné organizace global
Podobně sociální sítě (2890)
Data4You z.s.2898 |
|
WORKCAMP PARQUET, z.s.2900 |
|
Green Doors z.ú.2900 |
|
Římskokatolická farnost u kostela Panny Marie Sněžné Praha - Nové Město2900 |
|
KLUB VOJENSKÉ HISTORIE GARDEKORPS, PRAHA z.s.2900 |
Novinky
AAIC brings the opportunity to see so many friendly faces, including our 2025 Citizen Scientist elevated honoree, Rev. Dr. Cynthia Huling Hummel! She is continuing her advocacy and spoke on several panels about diagnosing and treating #Alzheimers disease. Our #CitizenScientists https://t.co/vvmOxCnA95 (tw)
As #AAIC25 brings 2gether researchers, clinicians and dementia professionals at the lgst international conference on dementia research we celebrate the winners from the Bio-Hermes Biomarker Data Challenge! Presenting the Winning Oral Presentation: “Functional Independence as an (tw)
Poslední komentáře
Absolutely inspired by the amazing work the Global Alzheimer’s Platform Foundation is doing! Together, we can support groundbreaking research and ensure that everyone has access to the treatments they need. 💙 #EndAlzheimersdetail |
|
So proud to see GAP leading the charge for diversity and inclusion in Alzheimer’s and Parkinson’s research! Let’s keep pushing for a brighter future for all those affected. 🌍✨ #TogetherForACuredetail |
Poslední diskuze
1. How can we further engage underrepresented communities in clinical trials for Alzheimer's and Parkinson's research to ensure diversity and inclusivity?Odpovědí: 3, Naposledy před 1 den detail |
|
2. What innovative strategies could be implemented to lower the cost and duration of clinical trials while maintaining high quality in Alzheimer's and Parkinson's disease research?Odpovědí: 3, Naposledy před 1 den detail |
V okolí
44
4.5
Washington
O společnosti
- G02 -
First of its kind Alzheimers Head to Head Study Comparing Leading Biomarkers Closes Unprecedented participation from underrepresented communities Menu Speeding up the delivery of Alzheimers Parkinsons Disease Treatments GAP and our over 100 clinical research partners GAPNet Sites around the world are collaborating to speed the delivery of Alzheimers and Parkinsons disease treatments with a commitment to promoting diversity in clinical research as well as lowering the cost and duration of clinical trials to ensure that no one is left behind. Nearly 7 Million Americans are currently living with Alzheimers disease. 141 Increase in deaths from Alzheimers between 2000 and 2021. 360 Billion The estimated cost of treating Alzheimers in the United States in 2024.
Správa a technická pomoc.